What to Know About Chemotherapy Drug Taxotere
Taxotere is a chemotherapy drug specifically designed to treat a variety of cancers including prostate, lung, stomach, neck, head, and breast cancer. Unfortunately, many patients are unaware of the medication’s long list of serious side effects that can include excessive tearing, tear duct blockage, and other eye-related issues.
The U.S. Food and Drug Administration (FDA) has taken note of several of these adverse effects that can cause long-term issues for cancer survivors. In fact, Taxotere manufacturer, Safoni, currently faces nearly 8,000 lawsuits over the harmful side effects faced by users.
The national product liability attorneys at Hotze Runkle PLLC know the dangers of Taxotere and want to expose the harsh realities of this commonly used drug.
Compensation for Serious Symptoms
Some of the most common side effects experienced by individuals treated with Taxotere include low white blood cell counts, swelling and weight gain, nausea, mouth sores, hair loss, fatigue, and even loss of nails. Most of these side effects do clear up after chemotherapy treatment is done.
However, your attorneys at Hotze Runkle PLLC have found there to be several lasting side effects such as excessive tearing of the eyes, blocked tear ducts, and other eye-related problems.
If you or a loved one have received chemotherapy treatment with the drug Taxotere and have noticed side effects of the drug that have extended beyond the period of treatment, there may be compensation available.
The Prevalent Use of Taxotere
Chemotherapy drugs like Taxotere work by killing fast-growing cancer cells in the body – both normal and cancerous. This drug attacks the RNA and DNA structures of the cells that allow them to reproduce effectively.
75 percent of individuals with breast cancer use the drug Taxotere in chemotherapy. Although there are other chemotherapy drugs on the market, the vast majority of individuals with breast cancer are treated with Taxotere because of its effectiveness and ability to be administered once every three weeks. Other forms of chemotherapy treatment can be administered only on a weekly basis.
FDA Releases Taxotere Truth
In 2015, the Sanofi Company and the FDA released a full description of warnings and adverse reactions for patients who used specific doses of the drug. Undoubtedly, many patients would have thought twice about choosing this particular chemotherapy if this information had been made readily available to them.
The warning reveals that Taxotere caused a number of serious conditions including:
- Acute Myeloid Leukemia – cancer of blood cells.
- Cystoid Macular Edema – loss of vision.
- Toxic Deaths
Prior to 2015, much of this information was unavailable to the public.
The drug has been administered for nearly 20 years and its effects have taken a toll on users and will continue to so with patients still receiving treatment with it.
The Sanfoni company should face the consequences of inflicting harm on you or your loved ones. Contact the product liability lawyers at Hotze Runkle PLLC for experienced help in seeking compensation from this negligent drug company.